Preview

Sechenov Medical Journal

Advanced search

Clinical case of thrombotic microangiopathy in obstetric practice

Full Text:

Abstract

Trombotic microangiopathy is heterogeneous group of the diseases united by a community of a histological and clinical implications at difference of pathogenetic mechanisms, presents clinical-morphological syndrome characterizing a lesion of vessels of a microcirculatory channel. Currently thrombotic microangiopathy include thrombotic thrombocytopenic purpura (TTP), atypical hemolytic uremic syndrome (aHUS), heparin-induced thrombocytopenia, HELLP-syndrome. One of the most important triggers of emergence of a thrombotic microangiopathy is pregnancy. The article describes the clinical observation of atypical hemolytic uremic syndrome in obstetric practice.

About the Authors

M. N. Mochalova
Chita State Medical Academy
Russian Federation


T. E. Belokrinitskaya
Chita State Medical Academy
Russian Federation


T. V. Haven
Chita State Clinical Hospital “Regional Clinical Hospital”
Russian Federation


E. M. Shifman
Vladimirsky MONIKI; Association of Obstetric Anesthesiologists-Reanimatologists
Russian Federation


K. G. Shapovalov
Chita State Medical Academy
Russian Federation


S. V. Kostromitin
Chita State Clinical Hospital “Regional Clinical Hospital”
Russian Federation


References

1. Fakhouri F., Vercel C., Fremeaux-Bacchi V. Obstetric Nephrology: AKI and Thrombotic Microangiopathies in Pregnancy. Clin. J. Am. Soc. Nephrol. 2012; 7: 2100-2106. DOI: 10.2215/CJN.13121211

2. Fakhouri F., Roumenina L., Provot F. et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J. Am. Soc. Nephrol. JASN. 2010; 21(5): 859-867

3. Акиньшина С.В., Бицадзе В.О., Гадаева З.К., Макацария А.Д. Значение тромботической микроангиопатии в патогенезе акушерских осложнений. Акушерство, гинекология и репродукция. 2015; 9(1): 62-71. DOI: 10.17749/2070-4968.2015.9.2.062-71

4. Kentouche K., Voigt A., Schleussner E. et al. Pregnancy in Upshaw-Schulman syndrome. Hamostaseologie. 2013; May 29; 33(2): 144-8

5. Gaudet L., Ferraro Z.M., Wen S.W., Walker M. Maternal Obesity and Occurrence of Fetal Macrosomia: A Systematic Review and Meta-Analysis. Biomed. Res. Int. 2014; 2014: 640291. DOI: 10.1155/2014/640291

6. Torok T.J., Holman R.C., Chorba T.L. Increasing mortality from thrombotic thrombocytopenic purpura in the United States-analysis of national mortality data, 1968-1991. Am. J. Hematol. 1995; 50: 84-90

7. Козловская Н.Л., Коротчаева Ю.В., Боброва Л.А., Шилов Е.М. Акушерский атипичный гемолитико-уремический синдром: первый российский опыт диагностики и лечения. Нефрология. 2016; 20(2): 68-80

8. Батюшин М.М. Атипичный гемолитико-уремический синдром при беременности и HELLP-синдром. Вопросы дифференциальной диагностики. Клиническая нефрология. 2015; 2-3: 46-51

9. Isler C.M., Barrilleaux P.S., Magann E.F. et al. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count syndrome). Amer. J. Obstet. Gynec. 2001; 184: 1332-9

10. Katz V.L., Farmer R., Kuler J.A. Preeclampsia into eclampsia: Towards a new paradigm. Amer. J. Obstet. Gynec. 2000; 182: 1389-94

11. Figueroa J.E., Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 1991; 4(3): 359-395

12. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001; 344(14): 1058-66. DOI: 10.1056/NEJM200104053441406

13. Rother R.P., Rollins S.A., Mojcik C.F. et al. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nature Biotech. 2007; 25(11): 1256-64. DOI: 10.1038/ nbt1344


Review

Views: 327


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2218-7332 (Print)
ISSN 2658-3348 (Online)